Provided by Tiger Trade Technology Pte. Ltd.

GENSCRIPT BIO

32.400
+0.4001.25%
Volume:38.87M
Turnover:1.26B
Market Cap:71.31B
PE:-16.81
High:33.760
Open:30.880
Low:30.800
Close:32.000
52wk High:37.360
52wk Low:10.360
Shares:2.20B
HK Float Shares:2.20B
Volume Ratio:1.07
T/O Rate:1.77%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.928
ROE:-15.33%
ROA:1.54%
PB:2.34
PE(LYR):-16.81
PS:10.76

Loading ...

US Treasury Turmoil Batters Tech Stocks While Banks Steady Hong Kong Market

Stock News
·
Aug 19

Movement Alert|GENSCRIPT BIO Rises 4.18% in Regular Trading, Multiple Institutions Raise Target Prices Following Earnings Beat

Market Focus
·
Aug 19

China's GenScript Biotech H1 Revenue Rises on AI Drug Discovery

Reuters
·
Aug 18

Genscript Biotech Corp H1 Revenue USD 319 Million

THOMSON REUTERS
·
Aug 18

GenScript Adjusted Net Profit More than Triples to Us$62.5 Million in FY26 H1; Revenue Rises 27.3% to Us$404.2 Million

Reuters
·
Aug 18

Genscript Reports 27.3% First-Half 2026 Revenue Growth as AI Drug Discovery Business Doubles

THOMSON REUTERS
·
Aug 18

Global Food Inflation Risks Return While Robotics Stocks Rally on Yushu Tech's Upcoming Debut

Stock News
·
Aug 18

Hong Kong Stocks Decline 0.3% in Early Trading

Dow Jones
·
Aug 18

HK Movers | Pharma Stocks Rally With Genscript Biotech up 6%, WuXi Biologics up 5%

Tiger Newspress
·
Aug 18

Movement Alert|GENSCRIPT BIO Rises 7.82% in Regular Trading, Interim Results Significantly Beat Expectations with AIDD Business Doubling

Market Focus
·
Aug 18

Genscript Biotech (SEHK:1548) Stock Near Doubles As Losses Deepen

Simply Wall St.
·
Aug 17

Asian Market's Estimated Value Stocks For August 2026

Simply Wall St.
·
Aug 17

Hong Kong Stock Moves: GENSCRIPT BIO Surges Over 4% as AIDD-Related Business Doubles in First Half

Stock News
·
Aug 17

HK Movers | Pharma Stocks Gain With HUTCHMED up 8%, JOINN up 6%

Tiger Newspress
·
Aug 17

Movement Alert|GENSCRIPT BIO Rises 3.3% in Regular Trading, H1 Adjusted Net Profit Surges 203% as AIDD Demand Accelerates

Market Focus
·
Aug 17

Genscript Biotech Widens Net Loss in H1

MT Newswires Live
·
Aug 17

GENSCRIPT BIO 2026 Interim Results: Soaring AIDD Demand Unlocks Vast Market Opportunities, Revenue and Profit Growth Far Exceeds Expectations, Core Businesses Achieve Comprehensive Breakthrough

Deep News
·
Aug 16

GenScript Biotech Posts 27.3% Revenue Growth and 203.3% Surge in Adjusted Profit in H1 2026, While Equity Accounting Hit Drives US$129.34 Million Net Loss

Bulletin Express
·
Aug 16

Genscript Biotech Says H1 Adjusted Net Profit up 203.3% Y/Y, Revenue up 27.3%

THOMSON REUTERS
·
Aug 16

GENSCRIPT BIO Reports Interim Results: Net Loss Narrows 29.25% to $129 Million

Stock News
·
Aug 16